相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults
Said A. Jongo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
Towards Eradication of Malaria: Is the WHO's RTS,S/AS01 Vaccination Effective Enough?
Navneet Arora et al.
RISK MANAGEMENT AND HEALTHCARE POLICY (2021)
Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine
Susheel K. Singh et al.
NPJ VACCINES (2021)
Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants
Srinivasa Reddy Bonam et al.
VACCINES (2021)
RTS,S/AS01 vaccine (Mosquirix?): an overview
Matthew B. Laurens
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
Roos M. de Jong et al.
IMMUNOLOGICAL REVIEWS (2020)
Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria
Dipak K. Raj et al.
NATURE (2020)
Malaria vaccines since 2000: progress, priorities, products
Patrick E. Duffy et al.
NPJ VACCINES (2020)
Malaria today: advances in management and control
Ashok K. Pannu
TROPICAL DOCTOR (2019)
Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants
Sofonias K. Tessema et al.
CELL HOST & MICROBE (2019)
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults
Said A. Jongo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Malaria Vaccines: Recent Advances and New Horizons
Simon J. Draper et al.
CELL HOST & MICROBE (2018)
The Promise of a Malaria Vaccine-Are We Closer?
Matthew B. Laurens
ANNUAL REVIEW OF MICROBIOLOGY, VOL 72 (2018)
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial
Kavita Singh et al.
NPJ VACCINES (2018)
Vaccines against malaria-still a long way to go
Kai Matuschewski
FEBS JOURNAL (2017)
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
Mahamadou S. Sissoko et al.
LANCET INFECTIOUS DISEASES (2017)
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Benjamin Mordmueller et al.
NATURE (2017)
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
Kirsten E. Lyke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection
Prakash Srinivasan et al.
NPJ VACCINES (2017)
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
Katharine A. Collins et al.
SCIENTIFIC REPORTS (2017)
Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine
Amber I. Raja et al.
INFECTION AND IMMUNITY (2017)
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
Ruth O. Payne et al.
JCI INSIGHT (2017)
Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection
Amber I. Raja et al.
INFECTION AND IMMUNITY (2016)
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
Andrew S. Ishizuka et al.
NATURE MEDICINE (2016)
Naturally acquired immunity to sexual stage P. falciparum parasites
Will J. R. Stone et al.
PARASITOLOGY (2016)
Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial
Myriam Arevalo-Herrera et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Malaria Parasites: The Great Escape
Laurent Renia et al.
FRONTIERS IN IMMUNOLOGY (2016)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
Michael T. White et al.
LANCET INFECTIOUS DISEASES (2015)
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
D. E. Neafsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
Thomas L. Richie et al.
VACCINE (2015)
Naturally Acquired Antibodies Specific for Plasmodium falciparum Reticulocyte-Binding Protein Homologue 5 Inhibit Parasite Growth and Predict Protection From Malaria
Tuan M. Tran et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
The path of malaria vaccine development: challenges and perspectives
C. Arama et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection
Dipak K. Raj et al.
SCIENCE (2014)
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
Selidji Todagbe Agnandji et al.
PLOS MEDICINE (2014)
Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
J. Kevin Baird
CLINICAL MICROBIOLOGY REVIEWS (2013)
Single-Dose Microparticle Delivery of a Malaria Transmission- Blocking Vaccine Elicits a Long-Lasting Functional Antibody Response
R.R. Dinglasan et al.
CURRENT MOLECULAR MEDICINE (2013)
RALP1 Is a Rhoptry Neck Erythrocyte-Binding Protein of Plasmodium falciparum Merozoites and a Potential Blood-Stage Vaccine Candidate Antigen
Daisuke Ito et al.
INFECTION AND IMMUNITY (2013)
Cross-species malaria immunity induced by chemically attenuated parasites
Michael F. Good et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The Malaria Vaccine Candidate GMZ2 Elicits Functional Antibodies in Individuals From Malaria Endemic and Non-Endemic Areas
Micha Phill Gronholm Jepsen et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36
Nirianne Marie Q. Palacpac et al.
PLOS ONE (2013)
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
Robert A. Seder et al.
SCIENCE (2013)
A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants
Leyla Y. Bustamante et al.
VACCINE (2013)
MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines
Kirsten S. Vannice et al.
MALARIA JOURNAL (2012)
Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru
Elizabeth Villasis et al.
MALARIA JOURNAL (2012)
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
Sara Mian-McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Superior Antimalarial Immunity after Vaccination with Late Liver Stage-Arresting Genetically Attenuated Parasites
Noah S. Butler et al.
CELL HOST & MICROBE (2011)
CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria
Arturo Reyes-Sandoval et al.
JOURNAL OF IMMUNOLOGY (2011)
Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
Meta Roestenberg et al.
LANCET (2011)
A 2020 vision for vaccines against HIV, tuberculosis and malaria
Rino Rappuoli et al.
NATURE (2011)
Protection against Malaria by MSP3 Candidate Vaccine
Sodiomon B. Sirima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Field Trial to Assess a Blood-Stage Malaria Vaccine
Mahamadou A. Thera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria
Ally Olotu et al.
PLOS ONE (2011)
Vaccines against malaria
Adrian V. S. Hill
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2011)
The case for a subunit vaccine against malaria
Robin F. Anders
TRENDS IN PARASITOLOGY (2011)
Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite
Johannes Friesen et al.
VACCINE (2011)
Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS
Elke S. Bergmann-Leitner et al.
VACCINE (2011)
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
Alexander D. Douglas et al.
NATURE COMMUNICATIONS (2011)
The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert
Katarina Radosevic et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria Is Not Endemic
H. M. El Sahly et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Molecular vaccines for malaria
Joseph T. Bruder et al.
HUMAN VACCINES (2010)
Recombinant protein vaccines against the asexual blood stages of Plasmodium falciparum
Robin F. Anders et al.
HUMAN VACCINES (2010)
Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria
Stephen L. Hoffman et al.
HUMAN VACCINES (2010)
Prime-boost vectored malaria vaccines Progress and prospects
Adrian V. S. Hill et al.
HUMAN VACCINES (2010)
Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses
Arturo Reyes-Sandoval et al.
INFECTION AND IMMUNITY (2010)
Evaluation of the Safety and Immunogenicity of the RTS,S/AS01E Malaria Candidate Vaccine When Integrated in the Expanded Program of Immunization
Selidji T. Agnandji et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36
Toshihiro Horii et al.
PARASITOLOGY INTERNATIONAL (2010)
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
Stefania Capone et al.
VACCINE (2010)
Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites
Nathan W. Schmidt et al.
PLOS PATHOGENS (2010)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
Vasee S. Moorthy et al.
MALARIA JOURNAL (2009)
Protection against a Malaria Challenge by Sporozoite Inoculation.
Meta Roestenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
Bernhards R. Ogutu et al.
PLOS ONE (2009)
Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
Caterina Guinovart et al.
PLOS ONE (2009)
Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
Mark E. Polhemus et al.
PLOS ONE (2009)
A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
Bertrand Lell et al.
PLOS ONE (2009)
Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
Seth Owusu-Agyei et al.
PLOS ONE (2009)
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
Issaka Sagara et al.
VACCINE (2009)
Safety and immunogenicity of GMZ2-a MSP3-GLURP fusion protein malaria vaccine candidate
Meral Esen et al.
VACCINE (2009)
The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity
Silayuv E. Bongfen et al.
VACCINE (2009)
Malaria Parasite Invasion of the Mosquito Salivary Gland Requires Interaction between the Plasmodium TRAP and the Anopheles Saglin Proteins
Anil K. Ghosh et al.
PLOS PATHOGENS (2009)
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Philip Bejon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Salim Abdulla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines
Melissa A. Penny et al.
PLOS ONE (2008)
Two decades of commitment to malaria vaccine development: GlaxoSmithKline biologicals
W. Ripley Ballou et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge
Claire L. Hutchings et al.
INFECTION AND IMMUNITY (2007)
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique:: a double blind randomised controlled phase I/IIb trial
John J. Aponte et al.
LANCET (2007)
Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial
Cornelus C. Hermsen et al.
VACCINE (2007)
Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25
Joanna Kubler-Kielb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts
T Kariu et al.
MOLECULAR MICROBIOLOGY (2006)
Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen
R Audran et al.
INFECTION AND IMMUNITY (2005)
Phase 1 vaccine trial of Pvs25H:: a transmission blocking vaccine for Plasmodium vivax malaria
EM Malkin et al.
VACCINE (2005)
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine
AK Mueller et al.
NATURE (2005)
A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses
E Prieur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites
SL Hoffman et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea
B Genton et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Progress and challenges for malaria vaccines
TL Richie et al.
NATURE (2002)
Binding and invasion of liver cells by Plasmodium falciparum sporozoites - Essential involvement of the amino terminus of circumsporozoite protein
D Rathore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia:: a randomised trial
KA Bojang et al.
LANCET (2001)
分享论文
